Hirokazu Makishima

Risk of subsequent primary cancers after carbon ion radiotherapy, photon radiotherapy, or surgery for localised prostate cancer: a propensity score-weighted, retrospective, cohort study

Osama Mohamad, Takahiro Tabuchi, Yuki Nitta et al. · The Lancet Oncology · 2019 · 104 citations · Full text

Medicine, Oncology, Surgery +17

Progressive hypofractionated carbon‐ion radiotherapy for hepatocellular carcinoma: Combined analyses of 2 prospective trials

Goro Kasuya, Hirotoshi Kato, Shigeo Yasuda et al. · Cancer · 2017 · 100 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia

Sarah Abu Kar, Ania Jankowska, Hirokazu Makishima et al. · Haematologica · 2012 · 79 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Carbon-Ion Radiation Therapy for Pelvic Recurrence of Rectal Cancer

Shigeru Yamada, Tadashi Kamada, Daniel K. Ebner et al. · International Journal of Radiation Oncology*Biology*Physics · 2016 · 77 citations · Full text

Medicine, Oncology, Radiation Oncology +15

Comparison of adverse effects of proton and X-ray chemoradiotherapy for esophageal cancer using an adaptive dose–volume histogram analysis

Hirokazu Makishima, Hitoshi Ishikawa, Toshiyuki Terunuma et al. · Journal of Radiation Research · 2015 · 61 citations · Full text

Medicine, Oncology, Radiation Oncology +17